Product NDC: | 63323-241 |
Proprietary Name: | Glycophos |
Non Proprietary Name: | SODIUM GLYCOLATE |
Active Ingredient(s): | 216 mg/mL & nbsp; SODIUM GLYCOLATE |
Administration Route(s): | INTRAVENOUS; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-241 |
Labeler Name: | Fresenius Kabi USA, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Start Marketing Date: | 20130513 |
Package NDC: | 63323-241-20 |
Package Description: | 10 VIAL, PLASTIC in 1 CARTON (63323-241-20) > 20 mL in 1 VIAL, PLASTIC |
NDC Code | 63323-241-20 |
Proprietary Name | Glycophos |
Package Description | 10 VIAL, PLASTIC in 1 CARTON (63323-241-20) > 20 mL in 1 VIAL, PLASTIC |
Product NDC | 63323-241 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SODIUM GLYCOLATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; INTRAVENOUS |
Start Marketing Date | 20130513 |
Marketing Category Name | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | SODIUM GLYCEROPHOSPHATE ANHYDROUS |
Strength Number | 216 |
Strength Unit | mg/mL |
Pharmaceutical Classes |